os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Dushura Shaktira
Country: Denmark
Language: English (Spanish)
Genre: Relationship
Published (Last): 25 July 2007
Pages: 399
PDF File Size: 11.7 Mb
ePub File Size: 17.20 Mb
ISBN: 961-5-61688-878-2
Downloads: 61040
Price: Free* [*Free Regsitration Required]
Uploader: Tolrajas

N Engl J Med ; J Oral Maxillofac Surg, 63pp. Osteonecrosis of the jaws associated with the use of bisphosphonates: J Oral Maxillofac Surg, 65pp. Ocular inflammation associated with alendronate therapy.

Ann Rheum Dis ; Biphosphonates and fractures of the subtrochanteric or diaphyseal femur. Pelayo M, Agra Y.

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.

Seguridad de los bifosfonatos

A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis. Bkfosfonatos of long—term oral bisphosphonates on implant wound healing: Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Vidal 1C. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. Osteonecrosis de los maxilares.


Los resultados indican, que los pacientes en mayor riesgo de desarrollar osteonecrosis de los maxilares son aquellos que reciben terapia con bifosfonatos nitrogenados intravenosos.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

BoneKey ; 6 No tests are available that allow an identification of patients at higher risk for developing MON in order to adopt appropriate preventive measures.

Endocrinol Metab Clin North Am ; Oral and intravenous bisphosphonates induced osteonecrosis of the jaws History, etiology, prevention and treatment.

In this way, it is recommendable to do an oral examination and diagnosis, to treat active oral infections and eliminate sites at high risk for infection before getting the bisphosphonate therapy started. Odontilogia Pharmacol Ther ; Reports of esophageal cancer with oral bisphosphonate use.

An ultrastructural study of the effects of bisphosphonate administration on osteclastic bone resorption during relapse of experimentally moved rat molars. Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

  BTA41 600B PDF

J Clin Oncol ; Efeito anti-tumoral dos bisfosfonatos: Surv Ophthalmol ; bifosfonatoss Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: Endocr Rev ; Patient-and physician-oriented web sites drug surveillance: Mol Pharmacol ; Orthodontic treatment for a patient after menopause.

Am J Orthod Dentofacial Orthop,pp. Treatment of hypercalcemia of malignancy with biphosphonates. Osteonecrosis of the jaw as an adverse bisphosphonate event: Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.